207 related articles for article (PubMed ID: 9667656)
1. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
Tollenaar RA; van Krieken JH; van Slooten HJ; Bruinvels DJ; Nelemans KM; van den Broek LJ; Hermans J; van Dierendonck JH
Br J Cancer; 1998 Jun; 77(11):1842-7. PubMed ID: 9667656
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.
Kaklamanis L; Savage A; Whitehouse R; Doussis-Anagnostopoulou I; Biddolph S; Tsiotos P; Mortensen N; Gatter KC; Harris AL
Br J Cancer; 1998 Jun; 77(11):1864-9. PubMed ID: 9667660
[TBL] [Abstract][Full Text] [Related]
3. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
4. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer.
Ilyas M; Hao XP; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Bodmer WF; Talbot IC
Gut; 1998 Sep; 43(3):383-7. PubMed ID: 9863484
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival.
Ofner D; Riehemann K; Maier H; Riedmann B; Nehoda H; Tötsch M; Böcker W; Jasani B; Schmid KW
Br J Cancer; 1995 Oct; 72(4):981-5. PubMed ID: 7547253
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
8. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
Zavrides HN; Zizi-Sermpetzoglou A; Panousopoulos D; Athanasas G; Elemenoglou I; Peros G
Folia Histochem Cytobiol; 2005; 43(1):31-6. PubMed ID: 15871560
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
10. bcl-2 protein expression is associated with better prognosis in colorectal cancer.
Leahy DT; Mulcahy HE; O'Donoghue DP; Parfrey NA
Histopathology; 1999 Oct; 35(4):360-7. PubMed ID: 10564391
[TBL] [Abstract][Full Text] [Related]
11. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
Qiu CZ; Wang C; Huang ZX; Zhu SZ; Wu YY; Qiu JL
World J Gastroenterol; 2006 Apr; 12(13):2011-5. PubMed ID: 16610049
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
13. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
Watson AJ; Merritt AJ; Jones LS; Askew JN; Anderson E; Becciolini A; Balzi M; Potten CS; Hickman JA
Br J Cancer; 1996 Apr; 73(8):889-95. PubMed ID: 8611422
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction.
Gorczyca W; Markiewski M; Kram A; Tuziak T; Domagala W
Virchows Arch; 1995; 426(3):229-33. PubMed ID: 7773501
[TBL] [Abstract][Full Text] [Related]
15. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis.
Nakanishi H; Ohsawa M; Naka N; Uchida A; Ochi T; Aozasa K
Oncology; 1997; 54(3):238-44. PubMed ID: 9143406
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma.
Zhao DP; Ding XW; Peng JP; Zheng YX; Zhang SZ
J Zhejiang Univ Sci B; 2005 Dec; 6(12):1163-9. PubMed ID: 16358373
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]